Heidi Chokeir (@BiotechHeidi) header
Heidi Chokeir (@BiotechHeidi) profile picture

Heidi Chokeir

@BiotechHeidi

Life science communicator. Wine lover. Quilt maker. Passionate about cooking amazing food for people I love.

 San Diego, California
facebook.com/heidi.chokeir
Joined March 2011
  • Tweets2.6K
  • Following857
  • Followers804
222Media
Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)Photo by Heidi Chokeir (@BiotechHeidi)
To find the best treatment for non-small cell lung cancer (#NSCLC), #BiomarkerTesting shouldn’t be skipped. This test allows doctors to understand your immune system’s ability to fight #cancer before treatment even begins. Talk with your doctor today about testing #PDL1:
Image from eFFECTOR Therapeutics (@eFFECTOR_Rx)
1
3
4
In the antibiotics pipeline We need Antibiotics for CRAB , but Polymyxins,again?! New Polymyxins w reduced toxicity & greater antimicrobial coverage (CRAB & PSA) MRX-8:A novel polymyxin B analog QPX9003(synthetic lipopeptide) A next-generation,IV-administered synthetic polymyxin
Image from Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward)
7
1
26
Our CEO @paulpetertak was included in @PharmaScrip annual outlook feature sharing his anticipations on the industry at large and within the immuno-oncology space. Read the full piece here: bit.ly/3sZhBNc
Image from Candel Therapeutics (@CandelTx)
2
1
1
Greatest thing ever..ja
This quoted post is unavailable.
Try viewing anyway · View on X
4
32
2
255
At Candel we aim to strive for women and young girls to have full and equal access to and participation in #STEM. Happy International Day of Women and Girls in Science! #WomenInSTEM
Image from Candel Therapeutics (@CandelTx)
2
1
Fascinating work expanding our insights into the pro-inflammatory effects of adenoviral gene constructs, which are used as COVID19 vaccines as well as oncolytic viral immunotherapies: ‘’Adenovirus vaccine vectors activated Vδ2+ γδT…lnkd.in/eyG3TVAr lnkd.in/eKx7rY7a
1
2
Candel Therapeutics is honored to have been invited to the @Nasdaq Opening Bell Ceremony yesterday! We look forward to progressing our efforts to fight cancer by developing novel oncolytic viral immunotherapies. $CADL
Image from Candel Therapeutics (@CandelTx)
2
5
Our CEO Kevin Appelbaum sat down with @GrinsteinJ of @GENBio to discuss the bold vision behind our company – a new way to treat age-old diseases, starting with #type2diabetes. Read the full piece here: genengnews.com/cardiovascula…
Image from Better Therapeutics (@Better_Tx)
1
1
Heidi Chokeir retweeted
Mike Dudley (@MikeMndudley) profile picture
Mike Dudley@MikeMndudley18 Sep 2021
Congratulations to the @Qpexbio team on publishing on the chemical development for Phase 3 readiness of the ultra-broad spectrum inhibitor QPX7728 that can be delivered IV and orally. @BARDA @AWG_News @gardp_amr @AMRActionFund
Scott Hecker (@scottjhecker) profile pictureScott Hecker@scottjhecker17 Sep 2021
Qpex Biopharma reports on an efficient process for manufacture of β-lactamase inhibitor QPX7728, featuring Ni-catalyzed boron insertion and enantioselective cyclopropanation pubs.acs.org/doi/10.1021/acs…
Scalable Synthesis of β‑Lactamase Inhibitor QPX7728 by Sequential Nickel-Catalyzed Boron Insertion...

Scalable Synthesis of β‑Lactamase Inhibitor QPX7728 by Sequential Nickel-Catalyzed Boron Insertion...

Abstract. We report the scalable, high-yielding, and highly selective synthesis of the β-lactamase inhibitor QPX7728 featuring two key synthetic steps: nic

pubs.acs.org
4
14
#transcript Dr. Steve Worland #eFFECTORTherapeutics Genomics 3.0 pioneer in selective translation regulator inhibitors #STRIs Two #cancer revolutions targeted therapies & #immunotherapies. STRIs 3rd way to compliment one or both of those.#NSCLC #SPAC empoweredpatientradio.com/us…
Empowered Patient Podcast: Using Selective Translation Regulator Inhibitors to Reinvigorate the...

Empowered Patient Podcast: Using Selective Translation Regulator Inhibitors to Reinvigorate the...

Dr. Steve Worland is President and CEO of eFFECTOR Therapeutics a pioneer in the Genomics 3.0 category putting to work the research on selective translation regulator inhibitors (STRIs) and the key...

empoweredpatientradio.com
1
2
Today, we announced that we earned a $60M milestone from our collaboration with Roche for dosing the first patient in the global Phase 2b PADOVA study of prasinezumab in patients with early Parkinson's disease. Learn more: bit.ly/3ocE45C
3
8
Interested in working with a great group of journalists during one of the most important times for health news? We've got two health editing jobs at @WSJ: Health Business Bureau Chief and Health & Science News Editor. You can find them here: wsj.jobs/
15
2
16
Our novel anti-#tau antibody presented at #ADPD2021 featured in this comprehensive take on #tau
BioCentury (@BioCentury) profile pictureBioCentury@BioCentury11 Mar 2021
Data from Roche’s anti-tau mAb call into question targeting N-terminus buff.ly/3cmzKew
2
1
2
Heidi Chokeir retweeted
Gene Kinney (@GGKinney) profile picture
Gene Kinney@GGKinney11 Mar 2021
A thoughtful article by Selina Koch @BioCentury reminding us that where and how pathogenic proteins like #tau are targeted is meaningful with respect to biological consequences #epitopematters
BioCentury (@BioCentury) profile pictureBioCentury@BioCentury11 Mar 2021
Data from Roche’s anti-tau mAb call into question targeting N-terminus buff.ly/3cmzKew
6
1
11
Woke corporations in America today think they can fire employees for their politics without legal liability. They’re mistaken. There’s a legal storm coming. See my op-ed today. newsweek.com/save-americas-w…
Save America's Workers from the Church of Wokeness

Save America's Workers from the Church of Wokeness

Woke corporations in America today think they can fire employees for their politics without legal liability. They're mistaken.

newsweek.com
15
47
11
126
.@US_FDA approves Nulibry, from $BBIO, to reduce the risk of death in newborns with a rare inherited metabolic disorder known as Molybdenum Cofactor Deficiency Type A fda.gov/news-events/press-an…
2
8
Happy #WomenInScience Day
Image from #MakeSmartcool® (@makesmartcoolus)
11
38
Today we recognize all the women and girls chasing knowledge in their respective disciplines across the world. We also celebrate the women molecular cell biologists, biomedical engineers, and doctors at Mind+Matter who innovate solutions for our clients. #WomenInScienceDay
Image from Mind+Matter US (@mindmatter_us)
1
1
The prognosis for people with #LupusNephritis is worse if you are #Black or #Hispanic. We are committed to including these communities in the development of our novel treatment #KZR616. See if you may qualify to participate in our #clinicaltrial: bit.ly/MSNct
1
1
Heidi Chokeir retweeted
Jeff Cranmer (@jeff_cranmer) profile picture
Jeff Cranmer@jeff_cranmer2 Feb 2021
$PRTA up 43% a/h
Prothena Corporation (@ProthenaCorp) profile pictureProthena Corporation
@ProthenaCorp1 Feb 2021
Excited to share our news with the #amyloidosis community: we are initiating a confirmatory Phase 3 AFFIRM-AL study of birtamimab in #ALamyoidosis. Learn more here: bit.ly/39zOYwp
Image from Prothena Corporation (@ProthenaCorp)
2
1
4
Load more